ClotCare: Blood Clots, Stroke, Heart Attack
Sunday, October 13, 2024
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

Leading Authority Reviews Advances in Pulmonary Embolism Diagnosis and Treatment

Henry I. Bussey, Pharm.D., FCCP, FAHA
April 2004

Review: Goldhaber, S Z. Pulmonary embolism. The Lancet 2004; 363:1295-1305.

The April 17, 2004 issue of the Lancet contains a state-of-the-art review by Samuel Z. Goldhaber, M.D. on pulmonary embolism (PE) diagnosis and treatment. Dr. Goldhaber first reviews predisposing factors for PE and discusses the presenting signs and symptoms. The importance of D-dimer testing to rule out PE and the emergence of computerized tomography as the preferred diagnostic tests are also discussed. Dr. Goldhaber also examines the importance of risk stratification based on clinical hemodynamics, echocardiography, and troponin levels in order to identify those individuals who may require thrombolytic therapy or embolectomy. Finally, Dr. Goldhaber discusses the importance of providing at-risk patients with appropriate venous thromboembolism prophylaxis both in the hospital and after discharge. The article also provides an easy to follow diagram to guide the clinician in diagnosing and risk stratifying the suspected PE patient.

The abstract of the article is available free of charge on PubMed, a service of the National Library of Medicine, at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15094276.

Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to webmaster@clotcare.org.

ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.

Blood Clot Activities Calendar

New Postings:

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2018 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-860-0487
Send comments to webmaster@clotcare.org.
Sunday, October 13, 2024